Conference Coverage

Switch back to human insulin a viable money saver

Publish date: June 24, 2018

 

REPORTING FROM ADA 2018

There was no industry funding. Dr. Luo is a consultant for Alosa Health and Health Action International.

SOURCE: Luo J et al. 2018 American Diabetes Association scientific session abstract 4-OR

Pages

Recommended Reading

Thyroid markers linked to risk of gestational diabetes
MDedge Family Medicine
Type 2 diabetes may promote Parkinson development
MDedge Family Medicine
NIH cans study that relied on millions in funding from alcohol companies
MDedge Family Medicine
In T2DM, healthy lifestyle lowers CVD risk, mortality
MDedge Family Medicine
Ethical violations scuttle NIH’s big alcohol study
MDedge Family Medicine
FDA okays fully implantable continuous glucose monitor/mobile app combo for diabetes
MDedge Family Medicine
FDA: MiniMed 670G now available for younger diabetes patients
MDedge Family Medicine
Patients going without as insulin prices skyrocket
MDedge Family Medicine
Average glucose, A1c discordance is common, highlights ADAG equation concerns
MDedge Family Medicine
T1D neuropathy declines as glycemic control improves
MDedge Family Medicine